Benjamin Bondue

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model

Souphalone Luangsay, Valérie Wittamer, Benjamin Bondue et al. · The Journal of Immunology · 2009 · 248 citations

Neutrophil-Mediated Maturation of Chemerin: A Link between Innate and Adaptive Immunity

Valérie Wittamer, Benjamin Bondue, Aude Guillabert et al. · The Journal of Immunology · 2005 · 242 citations · Full text

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

Toby M. Maher, Susanne Stowasser, Yasuhiko Nishioka et al. · The Lancet Respiratory Medicine · 2019 · 96 citations · Full text

Fibrosis, Extracellular Matrix Turnover, Inflammatory Lung Disease +7

ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia

Benjamin Bondue, Olivier Vosters, Patricia de Nadaı̈ et al. · PLoS Pathogens · 2011 · 90 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +17